Page 678 - Basic _ Clinical Pharmacology ( PDFDrive )

664 SECTION VI Drugs Used to Treat Diseases of the Blood, Inflammation, & Gout

PREP AR A TIONS A V AIL ABLE

GENERIC NAME AVAILABLE AS GENERIC NAME AVAILABLE AS
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS Anakinra Kineret
Aspirin, acetylsalicylic acid Generic, Easprin, others Auranofin Ridaura
Bromfenac Prolensa, Bromday Aurothioglucose Solganal
Celecoxib Celebrex Belimumab Benlysta
Choline salicylate Various Canakinumab Ilaris
Diclofenac Generic, Cataflam, Voltaren Certolizumab Cimzia
Diflunisal Generic, Dolobid Cyclophosphamide Generic, Cytoxan
Etodolac Generic, Lodine Cyclosporine Generic, Sandimmune
Fenoprofen Generic, Nalfon Etanercept Enbrel
Flurbiprofen Generic, Ansaid, Ocufen Gold sodium thiomalate Generic, Aurolate
(ophthalmic) Golimumab Simponi
Ibuprofen Generic, Motrin, Rufen, Advil (OTC), Infliximab Remicade
Nuprin (OTC), others Leflunomide Generic, Arava
Indomethacin Generic, Indocin Methotrexate Generic, Rheumatrex
Ketoprofen Generic, Orudis Mycophenolate mofetil Generic, Cellcept
Magnesium salicylate Doan’s Pills, Magan, Mobidin Penicillamine Cuprimine, Depen
Meclofenamate sodium Generic Rilonacept Arcalyst
Mefenamic acid Generic, Ponstel Rituximab Rituxan
Meloxicam Generic, Mobic Sulfasalazine Generic, Azulfidine
Nabumetone Generic Tocilizumab Actemra
Naproxen Generic (OTC), Naprosyn, Anaprox, Tofacitinib Xeljanz
Aleve (OTC)
Oxaprozin Generic, Daypro ACETAMINOPHEN AND OTHER ANALGESICS
Piroxicam Generic, Feldene Acetaminophen Generic, Tylenol, Tempra, Panadol,
Acephen, others
Salsalate, salicylsalicylic acid Generic, Disalcid
Ketorolac tromethamine Generic, Toradol
Sodium salicylate Generic
Tramadol Ultram
Sodium thiosalicylate Generic, Rexolate
DRUGS USED IN GOUT
Sulindac Generic, Clinoril
Allopurinol Generic, Zyloprim
Suprofen Profenal (Ophthalmic) *
Colchicine Generic , Colchrys
Tolmetin Generic, Tolectin Febuxostat Uloric
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS Pegloticase Krystexxa
Abatacept Orencia Probenecid Generic
Adalimumab Humira
Sulfinpyrazone Generic, Anturane
* Outside the United States.

REFERENCES Furst DE et al: Dose response and safety study of meloxicam up to 22.5 mg daily
in rheumatoid arthritis: A 12 week multi-center, double blind, dose response
General study versus placebo and diclofenac. J Rheumatol 2002;29:436.
Hatemi G et al: EULAR recommendations for the management of Behçet disease. Knijff-Dutmer EA et al: Platelet function is inhibited by non-selective non-steroidal
Ann Rheum Dis 2008;67:1656. anti-inflammatory drugs but not by cyclooxygenase-2-selective inhibitors in
Hellman DB, Imboden JB Jr: Rheumatologic, immunologic, and allergic disor- patients with rheumatoid arthritis. Rheumatology (Oxford) 2002;41:458.
ders. In: Papadakis MA, McPhee ST (editors). Current Medical Diagnosis & Lago P et al: Safety and efficacy of ibuprofen versus indomethacin in preterm
Treatment, 2017. McGraw-Hill Education, 2017. infants treated for patent ductus arteriosus: A randomized controlled trial.
Eur J Pediatr 2002;161:202.
Laine L et al: Serious lower gastrointestinal clinical events with non-selective
NSAIDs NSAID or coxib use. Gastroenterology 2003;124:288.
Chan FK et al: Celecoxib versus diclofenac and omeprazole in reducing the Moran EM: Epidemiological and clinical aspects of nonsteroidal anti-inflammatory
risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med drugs and cancer risks. J Environ Pathol Toxicol Oncol 2002;21:193.
2002;347:2104. Niccoli L, Bellino S, Cantini F: Renal tolerability of three commonly employed
Clevers H: Colon cancer—Understanding how NSAIDs work. N Engl J Med non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis.
2006;354:761. Clin Exp Rheumatol 2002;20:201.
Deeks JJ, Smith LA, Bradley MD: Efficacy, tolerability, and upper gastrointestinal Olsen AMS et al: Association of NSAID use with risk of bleeding and cardiovas-
safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: cular events in patients receiving antithrombotic therapy after myocardial
Systematic review of randomised controlled trials. BMJ 2002;325:619. infarction. JAMA 2015;313:805.